Immunological differences between classical phenothypes of multiple sclerosis

Journal of the Neurological Sciences

Volumn 349, Issue 1-2, 2015, Pages 10-14

  Iwanowski, Piotr ^a   Losy, Jacek ^a,b  

^a Poznan University School of Medicine   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Adhesion molecules; AntiGM3 antibodies; Demyelination; Neurodegeneration; PPMS; Primary progressive multiple sclerosis

Indexed keywords

B CELL ACTIVATING FACTOR; CXCL13 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GANGLIOSIDE; IMMUNOGLOBULIN M ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOTOXIN; OCRELIZUMAB; RITUXIMAB; VERY LATE ACTIVATION ANTIGEN 4;

AXONAL INJURY; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CLINICAL TRIAL (TOPIC); DEMYELINATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE FIBER DEGENERATION; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; BRAIN; CLASSIFICATION; DISEASE COURSE; FEMALE; IMMUNOLOGY; MALE; PATHOLOGY; PHENOTYPE;

BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHENOTYPE;

EID: 84924013228     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.12.035     Document Type: Review

References (59)

1. M. Bradl, and H. Lassmann Progressive multiple sclerosis Semin Immunopathol 31 4 Nov 2009 455 465 [PubMed PMID: 19730864]
2. A.J. Thompson, C.H. Polman, D.H. Miller, W.I. McDonald, B. Brochet, and M.M.X. Filippi Primary progressive multiple sclerosis Brain 120 Pt 6 Jun 1997 1085 1096 [PubMed PMID: 9217691]
3. D.H. Miller, and S.M. Leary Primary-progressive multiple sclerosis Lancet Neurol 6 10 Oct 2007 903 912 [PubMed PMID: 17884680]
4. C.H. Hawkes, and G. Giovannoni The McDonald Criteria for Multiple Sclerosis: time for clarification Mult Scler 16 5 May 2010 566 575 [PubMed PMID: 20194583]
5. D.A. Cottrell, M. Kremenchutzky, G.P. Rice, W.J. Koopman, W. Hader, and J. Baskerville The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis Brain 122 Pt 4 Apr 1999 625 639 [PubMed PMID: 10219776]
6. M. Koch, E. Kingwell, P. Rieckmann, and H. Tremlett The natural history of primary progressive multiple sclerosis Neurology 73 23 Dec 8 2009 1996 2002 [PubMed PMID: 19996074]
7. J. Antel, S. Antel, Z. Caramanos, D.L. Arnold, and T. Kuhlmann Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol 123 5 May 2012 627 638 [PubMed PMID: 22327362]
8. J. Francisco, M.F.F. Quintanaa, Vissia Vigliettaa, Antonio H. Iglesiasa, Yifat Merblb, and Guillermo Izquierdoc 1. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis 2008
9. H. Lassmann, W. Bruck, and C.F. Lucchinetti The immunopathology of multiple sclerosis: an overview Brain Pathol 17 2 Apr 2007 210 218 [PubMed PMID: 17388952]
10. I. Duran, E.M. Martinez-Caceres, J. Rio, N. Barbera, M.E. Marzo, and X. Montalban Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules Brain 122 Pt 12 Dec 1999 2297 2307 [PubMed PMID: 10581223]
11. A. Kutzelnigg, J.C. Faber-Rod, J. Bauer, C.F. Lucchinetti, P.S. Sorensen, and H. Laursen Widespread demyelination in the cerebellar cortex in multiple sclerosis Brain Pathol 17 1 Jan 2007 38 44 [PubMed PMID: 17493036]
12. S. Bramow, J.M. Frischer, H. Lassmann, N. Koch-Henriksen, C.F. Lucchinetti, and P.S. Sorensen Demyelination versus remyelination in progressive multiple sclerosis Brain 133 10 Oct 2010 2983 2998 [PubMed PMID: 20855416]
13. G. Giovannoni, J.W. Thorpe, D. Kidd, B.E. Kendall, I.F. Moseley, and A.J. Thompson Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease J Neurol Neurosurg Psychiatry 60 1 Jan 1996 20 26 [PubMed PMID: 8558145. Pubmed Central PMCID: 486184]
14. G.V. McDonnell, S.A. McMillan, J.P. Douglas, A.G. Droogan, and S.A. Hawkins Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease J Neurol 246 2 Feb 1999 87 92 [PubMed PMID: 10195402]
15. M. Ukkonen, K. Wu, B. Reipert, P. Dastidar, and I. Elovaara Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis Mult Scler 13 6 Jul 2007 701 707 [PubMed PMID: 17613596]
16. S.M. Leary, and A.J. Thompson Interferon beta-1a in primary progressive multiple sclerosis J Neurol Sci 206 2 Feb 15 2003 215 216 [PubMed PMID: 12559514]
17. M.S. Freedman, C. Metzig, L. Kappos, C.H. Polman, G. Edan, and H.P. Hartung Predictive nature of IgM anti-alpha-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis Mult Scler 18 7 Jul 2012 966 973 [PubMed PMID: 22183938. Pubmed Central PMCID: 3546632]
18. M. Schwarz, L. Spector, M. Gortler, O. Weisshaus, L. Glass-Marmor, and A. Karni Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis J Neurol Sci 244 1-2 May 15 2006 59 68 [PubMed PMID: 16480743]
19. M.S. Freedman, J. Laks, N. Dotan, R.T. Altstock, A. Dukler, and C.J. Sindic Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event Mult Scler 15 4 Apr 2009 422 430 [PubMed PMID: 19324980. Pubmed Central PMCID: 2850589]
20. C.J. Binder, P.X. Shaw, M.K. Chang, A. Boullier, K. Hartvigsen, and S. Horkko The role of natural antibodies in atherogenesis J Lipid Res 46 7 Jul 2005 1353 1363 [PubMed PMID: 15897601]
21. J. Brettschneider, T.D. Jaskowski, H. Tumani, S. Abdul, D. Husebye, and H. Seraj Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases J Neuroimmunol 217 1-2 Dec 10 2009 95 101 [PubMed PMID: 19879655]
22. E.C. Vamvakas, A.A. Pineda, and B.G. Weinshenker Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis J Clin Apher 10 4 1995 163 170 [PubMed PMID: 8770707]
23. D. Poehlau, J. Federlein, T. Postert, M. Sailer, F. Bethke, and L. Kappos Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis - outline of a double-blind randomized, placebo-controlled trial Mult Scler 3 2 Apr 1997 149 152 [PubMed PMID: 9291171]
24. N. Pigard, I. Elovaara, H. Kuusisto, R. Paalavuo, P. Dastidar, and K. Zimmermann Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression J Neuroimmunol 209 1-2 Apr 30 2009 114 120 [PubMed PMID: 19217671]
25. A.R. Rodriguez Orozco Intravenous immunoglobulin and mitoxantrone stop the progression of secondary progressive multiple sclerosis in a patient with interferon intolerance Rev Alerg Mex 51 3 May-Jun 2004 124 126 [PubMed PMID: 15314844]
26. A. Uccelli, E. Capello, D. Fenoglio, M. Incagliato, M. Valbonesi, and G.L. Mancardi Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis Ital J Neurol Sci 15 1 Feb 1994 51 53 [PubMed PMID: 8206747]
27. A.H. Cross, R.S. Klein, and L. Piccio Rituximab combination therapy in relapsing multiple sclerosis Ther Adv Neurol Disord 5 6 Nov 2012 311 319 [PubMed PMID: 23139702. Pubmed Central PMCID: 3487534]
28. N.L. Monson, P.D. Cravens, E.M. Frohman, K. Hawker, and M.K. Racke Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis Arch Neurol 62 2 Feb 2005 258 264 [PubMed PMID: 15710854]
29. L. Piccio, R.T. Naismith, K. Trinkaus, R.S. Klein, B.J. Parks, and J.A. Lyons Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis Arch Neurol 67 6 Jun 2010 707 714 [PubMed PMID: 20558389. Pubmed Central PMCID: 2918395]
30. P.S. Rommer, R. Patejdl, A. Winkelmann, R. Benecke, and U.K. Zettl Rituximab for secondary progressive multiple sclerosis: a case series CNS Drugs 25 7 Jul 2011 607 613 [PubMed PMID: 21699272]
31. B.O. Khatri, M.P. McQuillen, R.G. Hoffmann, G.J. Harrington, and D. Schmoll Plasma exchange in chronic progressive multiple sclerosis: a long-term study Neurology 41 3 Mar 1991 409 414 [PubMed PMID: 2006010]
32. R. Magliozzi, O. Howell, A. Vora, B. Serafini, R. Nicholas, and M. Puopolo Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology Brain 130 Pt 4 Apr 2007 1089 1104 [PubMed PMID: 17438020]
33. M. Krumbholz, D. Theil, S. Cepok, B. Hemmer, P. Kivisakk, and R.M. Ransohoff Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment Brain 129 Pt 1 Jan 2006 200 211 [PubMed PMID: 16280350]
34. S. Ragheb, Y. Li, K. Simon, S. VanHaerents, D. Galimberti, and M. De Riz Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid Mult Scler 17 7 Jul 2011 819 829 [PubMed PMID: 21372118]
35. R. Furlan, M. Rovaris, F. Martinelli Boneschi, M. Khademi, A. Bergami, and M. Gironi Immunological patterns identifying disease course and evolution in multiple sclerosis patients J Neuroimmunol 165 1-2 Aug 2005 192 200 [PubMed PMID: 15949850]
36. T. Revesz, D. Kidd, A.J. Thompson, R.O. Barnard, and W.I. McDonald A comparison of the pathology of primary and secondary progressive multiple sclerosis Brain 117 Pt 4 Aug 1994 759 765 [PubMed PMID: 7922463]
37. D.M. Muller, M.P. Pender, and J.M. Greer Chemokines and chemokine receptors: potential therapeutic targets in multiple sclerosis Curr Drug Targets Inflamm Allergy 3 3 Sep 2004 279 290 [PubMed PMID: 15379596]
38. K. Hawker, P. O'Connor, M.S. Freedman, P.A. Calabresi, J. Antel, and J. Simon Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial Ann Neurol 66 4 Oct 2009 460 471 [PubMed PMID: 19847908]
39. O. Kantarci Treatment of primary progressive multiple sclerosis Semin Neurol 33 1 Feb 2013 74 78 [PubMed PMID: 23709215]
40. H. Gensicke, D. Leppert, O. Yaldizli, R.L. Lindberg, M. Mehling, and L. Kappos Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis CNS Drugs 26 1 Jan 1 2012 11 37 [PubMed PMID: 22171583]
41. H. Lassmann Axonal injury in multiple sclerosis J Neurol Neurosurg Psychiatry 74 6 Jun 2003 695 697 [PubMed PMID: 12754330. Pubmed Central PMCID: 1738488]
42. H. Lassmann New concepts on progressive multiple sclerosis Curr Neurol Neurosci Rep 7 3 May 2007 239 244 [PubMed PMID: 17488590]
43. J. Booss, M.M. Esiri, W.W. Tourtellotte, and D.Y. Mason Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis J Neurol Sci 62 1-3 Dec 1983 219 232 [PubMed PMID: 6607973]
44. I. Nikic, D. Merkler, C. Sorbara, M. Brinkoetter, M. Kreutzfeldt, and F.M. Bareyre A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis Nat Med 17 4 Apr 2011 495 499 [PubMed PMID: 21441916]
45. D. Mahad, H. Lassmann, and D. Turnbull Review: mitochondria and disease progression in multiple sclerosis Neuropathol Appl Neurobiol 34 6 Dec 2008 577 589 [PubMed PMID: 19076696. Pubmed Central PMCID: 2981078]
46. C.M. Rice, D. Cottrell, A. Wilkins, and N.J. Scolding Primary progressive multiple sclerosis: progress and challenges J Neurol Neurosurg Psychiatry 16 Feb 2013 [PubMed PMID: 23418213]
47. J.N. Lycke, J.E. Karlsson, O. Andersen, and L.E. Rosengren Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis J Neurol Neurosurg Psychiatry 64 3 Mar 1998 402 404 [PubMed PMID: 9527161. Pubmed Central PMCID: 2170011]
48. M.M. Gresle, H. Butzkueven, and G. Shaw Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis Mult Scler Int 2011 2011 315406 [PubMed PMID: 22096635. Pubmed Central PMCID: 3195785]
49. N. Norgren, L. Rosengren, and T. Stigbrand Elevated neurofilament levels in neurological diseases Brain Res 987 1 Oct 10 2003 25 31 [PubMed PMID: 14499942]
50. J. Salzer, A. Svenningsson, and P. Sundstrom Neurofilament light as a prognostic marker in multiple sclerosis Mult Scler 16 3 Mar 2010 287 292 [PubMed PMID: 20086018]
51. C.E. Teunissen, C. Dijkstra, and C. Polman Biological markers in CSF and blood for axonal degeneration in multiple sclerosis Lancet Neurol 4 1 Jan 2005 32 41 [PubMed PMID: 15620855]
52. J. Romme Christensen, L. Bornsen, M. Khademi, T. Olsson, P.E. Jensen, and P.S. Sorensen CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis Mult Scler 24 Nov 2012 [PubMed PMID: 23178691]
53. B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis Brain Pathol 14 2 Apr 2004 164 174 [PubMed PMID: 15193029]
54. C.M. Dalton, P.A. Brex, R. Jenkins, N.C. Fox, K.A. Miszkiel, and W.R. Crum Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis J Neurol Neurosurg Psychiatry 73 2 Aug 2002 141 147 [PubMed PMID: 12122170. Pubmed Central PMCID: 1737988]
55. M. Bieniek, D.R. Altmann, G.R. Davies, G.T. Ingle, W. Rashid, and J. Sastre-Garriga Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis J Neurol Neurosurg Psychiatry 77 9 Sep 2006 1036 1039 [PubMed PMID: 16793860. Pubmed Central PMCID: 2077733]
56. N. Acarin, J. Rio, A.L. Fernandez, M. Tintore, I. Duran, and I. Galan Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis Acta Neurol Scand 93 2-3 Feb-Mar 1996 99 103 [PubMed PMID: 8741126]
57. B.T. Sadatipour, J.M. Greer, and M.P. Pender Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis Ann Neurol 44 6 Dec 1998 980 983 [PubMed PMID: 9851447]
58. A. Stevens, M. Weller, and H. Wietholter CSF and serum ganglioside antibody patterns in MS Acta Neurol Scand 86 5 Nov 1992 485 489 [PubMed PMID: 1481629]
59. M.P. Pender, P.A. Csurhes, N.P. Wolfe, K.D. Hooper, M.F. Good, and P.A. McCombe Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis J Clin Neurosci 10 1 Jan 2003 63 66 [PubMed PMID: 12464524]